Narrow Results By
Authorizing Cannabis for Medical Purposes
https://policybase.cma.ca/link/policy11514
- Last Reviewed
- 2020-02-29
- Date
- 2015-02-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11297
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
https://policybase.cma.ca/link/policy11519
Bill C-17 An Act to amend the Food and Drugs Act
https://policybase.cma.ca/link/policy11196
Bill C-45: The Cannabis Act
https://policybase.cma.ca/link/policy13723
Bill C-45: The Cannabis Act
https://policybase.cma.ca/link/policy13861
Canada’s lower-risk cannabis use guidelines (LRCUG)
https://policybase.cma.ca/link/policy13726
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
https://policybase.cma.ca/link/policy11129
- Date
- 2014-05-15
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Cannabis for Medical Purposes
https://policybase.cma.ca/link/policy10045
- Last Reviewed
- 2019-03-03
- Date
- 2010-12-04
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
https://policybase.cma.ca/link/policy10437
CMA Recommendations on Vaccine Equity and Intellectual Property
https://policybase.cma.ca/link/policy14476
- Date
- 2022-05-13
- Topics
- Ethics and medical professionalism
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Policy Type
- Parliamentary submission
- Date
- 2022-05-13
- Topics
- Ethics and medical professionalism
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
Documents
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
https://policybase.cma.ca/link/policy10702
CMA response to patented medicines regulations consultations
https://policybase.cma.ca/link/policy13690
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
https://policybase.cma.ca/link/policy13641
- Date
- 2017-04-07
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
https://policybase.cma.ca/link/policy13918
- Date
- 2018-02-15
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety